DIGITAL EDITION

ARCHIVES

CURRENT ISSUE

Alzheimer’s Therapies

by Elisa F. Cascade; Amir H. Kalali, MD; and Edmund Howe, MD, JD Ms. Cascade is Vice President, Strategic Research and Safety, Quintiles Inc., Falls Church, Virginia; Dr. Kalali is

The FDA and the Drug Approval Process

by William D. Schwieterman, MD, PhD; and Steven D. Targum, MD Dr. Targum is on the editorial board of Psychiatry 2007. Presently, he is Chief Medical Officer at Brain Cells

Lisdexamfetamine Dimesylate: The First Prodrug Stimulant

by David W. Goodman, MD Dr. Goodman is from the Adult Attention Deficit Disorder Center of Maryland, Johns Hopkins at Green Spring Station, Lutherville, Maryland; and Assistant Professor, Johns Hopkins

An Atomoxetine Tutorial

by David Feifel, MD, PhD Dr. Feifel is Associate Professor In Residence, Department of Psychiatry; Director, Neuropsychiatry and Behavioral Medicine Program; Director, UCSD Adult ADHD Program, University of California, San